Acute Pancreatitis Presentation

Embed Size (px)

Citation preview

  • 7/28/2019 Acute Pancreatitis Presentation

    1/24

    Case PresentationFamily Medicine Team C

    Gerry Martin, MDChristie Prendergast, MS3

    Annie Lim, MS3

  • 7/28/2019 Acute Pancreatitis Presentation

    2/24

    Case Presentation

    CC: Epigastric painHPI: 46 YO AA female presented to ER

    with 2 day Hx of abdominal pain. Pain is

    epigastric & periumblical, constant, 10/10,and radiates to back. Pain is worse with

    food, improved in fetal position. Denies

    NV, +diarrhea, +night chills. Precipitatedby EtOH binge 2 days prior.

  • 7/28/2019 Acute Pancreatitis Presentation

    3/24

    Case Presentation Continued

    PMHx: HTNx13 yrs, DMII x13yrs,

    hyperlipidemia, major depressive

    d/o (Hx of 5150), hx of acutepancreatitis.

    Pt also states BS have been in

    400s and has not f/u in clinic since

    3/07

  • 7/28/2019 Acute Pancreatitis Presentation

    4/24

    Case Presentation Continued

    PSurgHx: lumpectomyFamHx: mother HTN, father DM, mother CAD

    SocHx: 5-pack year hx, EtOH abuse (2-3 largedrinks/day)

    Meds:

    DM: Metformin 100mg, Glipizide 10mg,Pioglitazone 30 mg, Gabapentin 600 mg

    HTN: HCTZ 25mg, Simvastatin 40mg, ASA 81mg, Losartan 50 mg

    Depression: Citalopram 40 mg, Risperdal 6 mg

    Allergies: NKDA

  • 7/28/2019 Acute Pancreatitis Presentation

    5/24

    Case Presentation ContinuedPhysical Exam

    Vitals: BP:163/109 P:91 T:96 R:18

    Gen: pleasant, mildly distressed, obese female

    HEENT: non-icteric sclera

    CV: RRR, no murmurs appreciated

    Resp: CTAx2, no wheezing, rales, rhonchi

    GI: epigastric & RUQ tenderness, no rebound

    tenderness, negative Murphys, neg Cullens &Turners sign, +BSx4

    Ext/MSK: 5/5 bilateral UE, 5/5 bilateral LE, 2/4

    posterior tibal, 2/4 dorsalis pedis, 2/4 popliteal

    + monofilament test

  • 7/28/2019 Acute Pancreatitis Presentation

    6/24

    Case Presentation Continued

    Labs:133 99 11

    4.4 21 0.88.8

    13.9

    40.2221

    Accucheck: 363 216

    HgA1c = 13.9

    Lipids (3/07)

    TG 64

    Chol 250

    LDL 161

    441

    Lipase on admission 333

    AST/ALT = 13/12

    Urine

    B-hydroxy = 2.60 ( )

    +ketones + glucose

    Cardiac enzymes neg x2

  • 7/28/2019 Acute Pancreatitis Presentation

    7/24

    Case Presentation Continued

    Imaging

    CT scan: acute on chronic pancreatitis

    CXR: normalEKG: NSR

  • 7/28/2019 Acute Pancreatitis Presentation

    8/24

    Diagnosis

    Acute Pancreatitis secondary

    to EtOH abuse

  • 7/28/2019 Acute Pancreatitis Presentation

    9/24

    Assessment/Plan

    1. Acute Pancreatitis 2/2 EtOH abuseRansons criteria score 1clear liquids, IV fluids, Morphine sulfateCBC/Chem, Lipid panel

    2. DM II poor controlHgA1c=14.9Start Levemir 14U qHS

    Hold oral hypoglycemic meds3. HTN poor control

    continued current BP meds and BPmonitoring

  • 7/28/2019 Acute Pancreatitis Presentation

    10/24

    Assessment/Plan Continued

    4. HyperlipidemiaLDL 161 (3/07)Continue ZocorRechecked fasting lipid panel (LDL 103)

    5. Major Depressive D/O stable

    Continue current management

    6. EtOH abuse

    Counseled patient on EtOH complications &importance of cessation

    7. Tobacco abuse

    Smoking cessation counseling

  • 7/28/2019 Acute Pancreatitis Presentation

    11/24

    Differential Diagnosis

    1. Acute cholecystitis

    2. Intestinal obstruction

    3. Mesenteric vascular occlusion4. Renal colic

    5. MI

    6. Pneumonia

  • 7/28/2019 Acute Pancreatitis Presentation

    12/24

    Ransons Criteria/Prognosis

    On admission:1. Age >55 YO

    2. WBC > 16K

    3. Glucose > 2004. LDH > 350

    5. AST >250

    At 48 hrs:1. Ca < 8

    2. Hct > 10%

    3. BUN > 5mg/dL4. Base deficit > 4meq/L

    5. PaO2 < 60mmHg

    6. Fluid seq > 6L

  • 7/28/2019 Acute Pancreatitis Presentation

    13/24

    Hospital Course

    Patient was placed on clear liquids, IVhydration, and given morphine for paincontrol. She stayed in the hospital for 2

    days. On HD#2 pain decreased,amylase/lipase levels decrease (17/86)and patient tolerated diabetic diet withoutany exacerbation of symptoms. Pt was

    extensively counseled on diabetic control,and smoking/EtOH cessation. Pt was thendischarged home with follow-up in clinic.

  • 7/28/2019 Acute Pancreatitis Presentation

    14/24

    DISCUSSIONQuestions?

  • 7/28/2019 Acute Pancreatitis Presentation

    15/24

    Introduction

    Definition: Acute pancreatitis is aninflammatory condition of the pancreascharacterized clinically by abdominal pain

    and elevated levels of pancreatic enzymesin the blood

    Prevalence in United States is79.8/100,000 per year, thus resulting in185,000 new cases of acute pancreatitisannually

  • 7/28/2019 Acute Pancreatitis Presentation

    16/24

    Etiology of Pancreatitis

    1. Gallstones2. Alcohol3. Hypertriglyceridemia4. Hypercalcemia5. ERCP6. Trauma7. Postoperative

    8. Rx (sulfas, diuretics, HIV Rx, ASA)9. Infections10.+many more uncommon causes

  • 7/28/2019 Acute Pancreatitis Presentation

    17/24

    Signs & Symptoms

    Acute upper abdominal pain (90%)

    Radiates to the back

    NauseaVomiting

    Relief on bending forward

  • 7/28/2019 Acute Pancreatitis Presentation

    18/24

    Physical Exam

    Mild: epigastric tenderness

    Severe:

    fever, tachycardia, shock, coma

    Respiratory distress

    Grey turners or Cullens sign

    Epigastric mass

  • 7/28/2019 Acute Pancreatitis Presentation

    19/24

    Laboratory/Imaging

    Elevated amylase/lipase

    CRP >150 mg/dl discriminates severefrom mild

    Ultrasound to r/o gallstone pancreatitis

    Abdominal X-ray range from unremarkableto localized ileus (sentinel loop/colon cutoff

    sign) CXR to r/o pleural effusion, elevation of

    diaphragm, ARDS

  • 7/28/2019 Acute Pancreatitis Presentation

    20/24

    Laboratory/Imaging

    CT Scan assess the severity

    MRI lacks nephrotoxicity, better

    categorize fluid collection, necrosis,

    abscess, hemorrhage and pseudocyst.

    Equivocal to ERCP

  • 7/28/2019 Acute Pancreatitis Presentation

    21/24

    CLINICAL PREDICTORS

    Scoring systems

    APACHE II uses physiology, age and

    chronic health to calculate prognosis

    Ranson, Glasgow, Bank takes 48 hours to

    complete, can be used only once

  • 7/28/2019 Acute Pancreatitis Presentation

    22/24

    Treatment

    General Principles: Correction of

    underlying predisposing factors

    Gallstone Pancreatitis: Early ERCP in

    patients with biliary sepsis and obstructive

    jaundice

    Reversal of hypercalcemia

    Cessation of causative agent/drugs

    Administration of insulin to poorly controlled

    diabetics with hypertriglyceridemia

  • 7/28/2019 Acute Pancreatitis Presentation

    23/24

    Treatment Mild pancreatitis supportive care

    Severe pancreatitis ICU monitoring

    Support of pulmonary, renal, circulatory,hepatobiliary function

    Fluid resuscitation(250-300 cc/hr) Pain management meperidine, morphine,

    fentanyl

    Preventing infection: Selective decontamination

    of the gut by oral nonabsorbable abx Systemic Antiobiotics: studies evaluating its

    benefit and harm is still unsettled

  • 7/28/2019 Acute Pancreatitis Presentation

    24/24

    Treatment

    Nutritional support with early enteralfeeding reduces complications

    Parenteral nutrition required if enteral

    feeding not tolerated Necrotizing Pacreatitis (30% of pancreas),

    meropenem/imipenem

    Surgical referral: unstable, failure of Rx